Anti-Jcv Antibody Detection Assay
OYP is the FDA product code for Anti-Jcv Antibody Detection Assay, a class II device type, regulated under 21 CFR 866.3336. FDA's definition for this code reads: "The anti-jcv antibody detection assay is intended for the detection of antibodies to the john cunningham virus (jcv) in serum or plasma samples from multiple sclerosis (ms) and crohn's disease (cd) patients receiving immunomodulatory therapies". As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- OYP
- Device name
- Anti-Jcv Antibody Detection Assay
- FDA definition
- The anti-jcv antibody detection assay is intended for the detection of antibodies to the john cunningham virus (jcv) in serum or plasma samples from multiple sclerosis (ms) and crohn's disease (cd) patients receiving immunomodulatory therapies.
- Regulation
- 21 CFR 866.3336
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 2
- Ingested recalls
- 1
Clearances, product code OYP
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2012 | 2 |
Applicants with the most clearances
Product code OYP| Applicant | Clearances |
|---|---|
| DiaSorin Molecular LLC | 2 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
